Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Farnesyl pyrophosphate (Farnesyl diphosphate), a 15-carbon isoprenoid derived from the mevalonate (MVA) pathway, acts as a metabolic intermediary. It serves as a TRPM2 (TRP Channel) agonist, facilitating the opening of TRPM2 channels for ion influx. Additionally, it plays a critical role in the biosynthesis of cholesterol, ubiquinones, and geranyl-geranyl pyrophosphate (GGPP), as well as in the process of protein farnesylation decoration [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | Farnesyl pyrophosphate (Farnesyl diphosphate), a 15-carbon isoprenoid derived from the mevalonate (MVA) pathway, acts as a metabolic intermediary. It serves as a TRPM2 (TRP Channel) agonist, facilitating the opening of TRPM2 channels for ion influx. Additionally, it plays a critical role in the biosynthesis of cholesterol, ubiquinones, and geranyl-geranyl pyrophosphate (GGPP), as well as in the process of protein farnesylation decoration [1]. |
Molecular Weight | 382.33 |
Formula | C15H28O7P2 |
CAS No. | 13058-04-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Farnesyl pyrophosphate 13058-04-3 inhibitor inhibit